About Delta Biotechnology
Delta Biotechnology is a Healthcare company based in Nottingham (United Kingdom) founded in 2020, and was acquired by Novozymes in July 2006. It operates as a developer of recombinant protein products. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include Liberation Labs, Core Biogenesis, Qkine, Future Fields and Protera and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
Delta Biotechnology was founded in 2020 and is based in Nottingham, United Kingdom. Operations center on the biotechnology sector, where recombinant protein products are developed using yeast platforms. These products support cell culture media and protein drug formulations. Services are provided to pharmaceutical, healthcare, and biotech companies for the production of human therapeutics. Focus remains on enabling manufacturing processes in these industries.
- Headquarters Nottingham, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website deltabiotechnology.com
- Acquired by Novozymes (Jul 2006)
Investors in Delta Biotechnology
Delta Biotechnology has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novozymes.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | novozymes.com | Bagsvaerd, Denmark |
Investor details for Delta Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Delta Biotechnology
2 dated milestones of Delta Biotechnology across 14 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by Novozymes.
- Founded Delta Biotechnology is founded.
Competitors of Delta Biotechnology
Delta Biotechnology has 10 listed competitors in our database, 9 of them funded. They include Liberation Labs, Core Biogenesis, Qkine, Future Fields and Protera, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| liberationlabs.com | 2022 | New York, United States | $107.61M | – | Fermentation products are manufactured and commercialized via CRO services. | |
| corebiogenesis.com | 2020 | Paris, France | $14.12M | – | UBaaS platform for plant-based recombinant protein bioproduction is offered. | |
| qkine.com | 2016 | Cambridge, United Kingdom | $8.15M | 15 | Animal-free growth factors are developed for life science applications. | |
| futurefields.io | 2017 | Edmonton, Canada | $21.55M | 28 | Serum-free bioactive growth factors and recombinant proteins are biomanufactured. | |
| proterabio.com | 2018 | Sunnyvale, United States | $15.85M | – | Protein-based enzyme technologies are developed using deep learning algorithms. | |
| njbio.com | 2018 | North Brunswick, United States | – | 84 | Clinical development services are provided for biotechnology applications. | |
| kinaxo.de | 2005 | Saarwellingen, Germany | $1.38M | – | Chemical proteomics for cellular target profiling and drug discovery services | |
| icongenetics.com | 1999 | Halle, Germany | $14.6M | 25 | Biopharmaceuticals and proteins are developed using green plants as hosts. | |
| shantani.com | 2010 | Pune, India | $987,612 | – | Drug discovery services are delivered via chemical-proteomics technologies. | |
| algenex.com | 2005 | Madrid, Spain | $13.28M | – | Developer of recombinant biologics for animal and human health |
Detailed competitors of Delta Biotechnology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Delta Biotechnology (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Delta Biotechnology
Delta Biotechnology was founded in 2020.
Delta Biotechnology is headquartered in Nottingham, United Kingdom.
Delta Biotechnology was founded in 2020 and is based in Nottingham, United Kingdom. Operations center on the biotechnology sector, where recombinant protein products are developed using yeast platforms. These products support cell culture media and protein drug formulations. Services are provided to pharmaceutical, healthcare, and biotech companies for the production of human therapeutics. Focus remains on enabling manufacturing processes in these industries.
Delta Biotechnology's top competitors include Liberation Labs, Future Fields and Qkine.
Delta Biotechnology has 1 investor. Key investors include Novozymes.
Yes. Delta Biotechnology was acquired by Novozymes in July 2006.